(Submitted for publication May 18, 1962; accepted July 3, 1962) Beginning with the report of Ziff, Kibrick, Dresner, and Gribetz (2) , evidence accumulated in recent years has indicated that urinary hydroxyproline excretion reflects collagen metabolism, since collagen is the only protein in the body that contains hydroxyproline in significant amounts (3). Ziff and co-workers, observing that the excretion of this amino acid in peptide form was greater in children than in adults, suggested that the level of urinary hydroxyproline might be related to the size of the metabolically active, soluble collagen pool available for breakdown. The results of a number of investigations (4-7) have supported this suggestion.
In the present paper, further investigation of the relationship between growth and hydroxyproline excretion has been carried out in man. Urinary hydroxyproline has been determined in patients with normal, arrested, and accelerated growth, and in cases in which arrested growth has been stimulated by hormonal therapy. The data obtained indicate that the level of excretion of hydroxyproline shows a good correlation with rate of growth under all circumstances studied and, therefore, offers a useful and readily measured index of this phenomenon.
METHODS AND MATERIALS
Normal controls. Urines from normal children and adults were collected at home. In the 0-to 1-year group, the urine was collected in absorbent diapers with a special tissue paper sheet to isolate the feces. Diapers were changed six times in 24 hours. Upon removal, they were immersed in water saturated with toluene, and at the end of a 24-hour collection period, centrifuged in * Work supported by a grant from the Department of Medical Care, National Foundation, and by grant no. 2A-5154, N.I.A.M.D., U. S. Public Health Service; published in part in abstract form (1) .
t Trainee in Arthritis, N.I.A.M.D., U. S. Public Health Service. a washing machine and then extracted three times with more water. The pooled extract and washings had a final volume of about four liters. A suitable sample was then taken for determination of hydroxyproline. Recoveries of this amino acid, carried out by soaking diapers with a known amount of urine, averaged 97 per cent.
Hospitalized controls. Individuals with diseases in which marked alteration of collagen synthesis, breakdown, or excretion might be present were not accepted as controls. Accordingly, patients with anorexia, malnutrition, acute infection, renal disease, dystrophy, and inborn errors of connective tissue metabolism were excluded. Urines from hospitalized infants were collected by means of a metabolic bed or by use of a finger cot attached to polyethylene tubing.
In eleven hospitalized, adult control subjects, the breakdown of diseases was as follows: myocardial infarction, 1; convalescent rheumatic fever, 1; inactive pulmonary tuberculosis, 2; post-delirium tremens, 1; osteoarthritis, 2; compensated alcoholic cirrhosis, 1; hypertensive cardiovascular disease, 1; arteriosclerotic heart disease, 1; and scleroderma, 1. In 44 hospitalized children, the following conditions were represented: club foot, 4; postpoliomyelitis under rehabilitation, 14; convalescent salmonellosis, 1; convulsive disorder, 3; inactive rheumatic fever, 1; convalescent meningitis, 4; post-arsenic poisoning, 1; convalescent pneumonia, 3; pes planus, 1; cystic fibrosis, 1; scoliosis, 1; croup, 1; inactive tuberculosis, 1; bronchitis, 3; rheumatoid arthritis, 1; infectious mononucleosis, 1; cellulitis, 1; psychiatric disorder, 1; and sicklecell anemia, 1. A gelatin-free diet was instituted at least one day before the collection period. Urines were collected under toluene and samples stored at -150 C. Unless otherwise specified, values represent averages of two consecutive 24-hour collections.
Total and free hydroxyproline were determined by the method of Prockop and Udenfriend (8) with the following modifications. To a 2-ml sample containing 2 to 10 ,ug of hydroxyproline, there were added 2 g of solid potassium chloride, 0.3 ml of a 10 per cent alanine solution, pH 8.7, and 0.7 ml of 0.25 N borate buffer, pH 8.7 . Oxidation was carried out with 0.6 ml of 0.2 M chloramine-T in methyl Cellosolve for 20 minutes at room temperature. The reaction was stopped by addition of 2 ml of 3.6 M sodium thiosulfate. The samples were then extracted once with 3.3 ml of toluene and the toluene layer discarded. A second volume of 3.3 ml of toluene was 1928 then added and the mixture allowed to stand in a boiling water bath for 30 minutes. Color development was carried out by adding 0.6 ml of para-dimethylaminobenzaldehyde reagent to 1.7 ml of the toluene layer. Samples were analyzed in duplicate. Unless otherwise specified, the values given in the text represent total hydroxyproline.
Total urinary amino acids were determined by the method of Troll and Cannan (9) .
Nitrogen and potassium balance. The pituitary dwarf S. B. was subjected to a 5-week balance study. The food supply was obtained in advance to assure uniformity. The diet was gelatin-free and afforded 700 kg-cal daily. Urine and feces were collected each day and frozen. Nitrogen analysis of food, urine, and feces was carried out by the combined macro-Kjeldahl and Conway diffusion techniques (10) . Potassium was determined on the flame photometer with internal standards.
RESULTS
Normal growth. Table I gives the daily total urinary hydroxyproline excretion observed in adult control subjects, both normal and hospitalized (Figure 1) , and pituitary dwarfism, presumed to be due to isolated growth hormone deficiency.
The patient was placed on a controlled, gelatinfree diet, and after 2 weeks of weight stabilization, 2.5 mg of human growth hormone 1 was administered intramuscularly 6 days a week, for 4 weeks. At the end of treatment, the patient had gained 700 g and grown 1.5 cm. Potassium and nitrogen balance studies indicated an immediate increase in retention of these elements, more pronounced in the first week of treatment. Figure 2 shows the levels of total urinary hydroxyproline in the periods before, during, and for three weeks after administration of growth hormone. Of note are the consistently low values, averaging 14.1 mg daily, observed during the control period, and the prompt rise in excretion after the start of treatment. At the end of the treatment period, the patient had achieved a urinary hydroxyproline level of 63.5 mg in 24 hours. The calculated value of 115.5 mg per m2 corresponds to a level attained by children only during periods of rapid growth (see Table II ). That this increase was not due to a nonspecific rise in urinary amino acids is shown by the fact that these increased only 50 per cent (see Figure 2) (Case 2)-W. R., a 10.5-year-old white grew normally during the first year of life. ginning at 14 months of age, he had a numbet hospital admissions because of convulsions as ciated with hypoglycemia. At 3.7 years, try ment with 10 mg of hydrocortisone daily was gun and continued intermittently until 4 we before admission, when steroid treatment i discontinued. On admission, height was 1C cm and weight, 30.0 kg. Growth rate during 3 years before admission had been half the r mal rate. At 7.5 years, RAI uptake was 28.1 cent, and urinary 17-ketosteroids, 2.3 mg per hours. Laboratory findings on admission wE urinary 17-hydroxy-corticosteroid excretion, to 1.8 mg per 24 hours (normal, 2 to 8 mg); l nary 1 1-desoxy-corticosteroids (normal, 0 tF mg per 24 hours); and plasma 1 1-desoxy-cc costeroids (normal, 0 to 2.5 ug per cent), ur tectable. After oral administration of 1 g methopyrapone (SU-4885, Ciba) in 4 divi doses over a 24-hour period, urinary 17-hydro corticosteroid excretion was 3.0 mg per 24 hot urinary 11-desoxy-corticosteroids, 0.9 to 1.5 per 24 hours (normal, > 8 mg); and plasma desoxy-corticosteroids, 1 est observed in the entire child (see Table II Figure 5 ). Three months after the course of radiation therapy ended, the excretion had decreased to 58.3 mg, or 28.3 mg per M2, and a similar value of 60.8 mg, or 29.5 mg per M2, was obtained 6 months later. Both post-treatment values were in the upper range of normal. Free urinary hydroxyproline in the pretreatment urines represented 1 to 2 per cent of the total. Five additional patients with the diagnosis of acromegaly were studied in whom there was no evidence of clinical activity. One had an elevated total excretion of 84.1 mg per 24 hours, and four showed excretion values in the upper range of normal (see Figure 5 ).
DISCUSSION
Growth in childhood expressed in increment of body surface area per year is especially rapid in the first year of life and above age 10 for girls and 12 for boys, and relatively slower in the intervening period (12) .2 Accordingly, the excretion data in children representing the combined values of both sexes were grouped in 0-to 1-, 1-to 10-and 10-to 14-year age groups. Significant differences in absolute excretion between children and adults were noted only in the 10-to 14-year group, where size difference is less marked. When excretion was calculated per unit surface area, however, to correct for the influence of size, significant elevation above the adult average was noted in all childhood age groups. Surface area was chosen as a parameter of size because it was thought to be a more reliable index of connective tissue mass than body weight.
The excretion values per square meter given in Table II are significantly greater in the 0-to 1-and 10-to 14-year groups than in the 1-to 10-year group, indicating a correlation between hydroxyproline excretion per unit surface area and growth rate, since, as mentioned above, growth is known to be more rapid in these two age periods. These findings suggest that when sufficient data are available, it will be possible to relate excretion per unit surface area to the normal growth curve.
All ten children with dwarfism showed low ex- 2 Values for the fiftieth percentile of height and weight in normal children (12) were used to calculate surface area. cretion of hydroxyproline. On an absolute basis, the values in nine of these fell between 5.5 and 17.3 mg, or below the range of the control values for normal children. Seven of the ten had low values per unit surface area, and the remaining three, who were known to be growing slowly, had borderline values. The low excretion observed in non-growing or slowly growing children is further evidence for a relationship between hydroxyproline excretion and growth.
Most impressive was the rise in excretion of hydroxyproline following hormonal treatment of non-growing endocrine dwarfs. When growth hormone was administered to two pituitary dwarfs and desiccated thyroid to three cretins, excretion of hydroxyproline rose dramatically in all cases, and this was accompanied by objective evidence of growth. All five dwarfs attained levels of excretion that were characteristic of actively growing children. In the case of two of the cretins, the values calculated per square meter were the highest ever noted by this laboratory in any age group. When, in the case of the two pituitary dwarfs, administration of growth hormone was halted, excretion returned to pretreatment values within 3 weeks.
Further evidence of a relationship between hydroxyproline excretion and growth was seen in the markedly elevated values observed in the patient with active acromegaly. Before treatment, these were three times the adult average; 3 months after irradiation, they had fallen to near normal levels. The data in five patients with clinically inactive acromegaly were more difficult to interpret. Excretion ranged between 49.7 and 84.1 mg, that is, from above normal to the upper limits of normal. Whether this indicates residual activity, undetectable by the usual criteria, is not clear.
Any mechanism attempting to explain the observed relationship between growth rate and excretion of hydroxyproline ought to take into consideration the presence of increased amounts of soluble collagen in the tissues of growing animals (13) (14) (15) (16) , presumably as a consequence of an increased rate of synthesis of this protein. This fraction has a high turnover rate and is the precursor of fibrous collagen. It is also known that urinary hydroxyproline is increased in young animals as compared with adults (5, 6). These con-siderations, as well as the results reported in this paper, agree with an earlier suggestion (2) that the increased excretion associated with growth represents peptides derived from soluble collagen.
Data recently obtained in this laboratory in rats with osteolathyrism (7) also support the point of view above. These animals had increased amounts of neutral salt-extractable collagen in the skin and excreted urinary hydroxyproline at elevated levels without gross differences in growth rate from control animals. This finding indicates that hydroxyproline peptide excretion rises with an increase in soluble collagen even when the latter change occurs as a result of factors other than growth. In this connection, an increased excretion of hydroxyproline has recently been reported in patients with Paget's disease and hyperparathyroidism (17) , conditions in which the rate of formation of new collagen in bone is presumably increased.
Although the arguments presented strongly suggest that the increased excretion during growth depends on an increase in soluble collagen, it is difficult to evaluate the contribution of the fibrous collagen to urinary hydroxyproline. Although this fraction turns over very slowly (18) , it is present in large amounts. Lindstedt and Prockop (5) have recently demonstrated a urinary hydroxyproline fraction in adult rats with a turnover rate of about 300 days, which they suggested was derived from the fibrous collagen pool. It is possible, therefore, that fibrous collagen does contribute to urinary hydroxyproline, and since there is little soluble collagen in adult tissue (19) , the contribution from mature fiber would be proportionately greater in this group than in children.
In considering other possible explanations for the increased excretion of hyroxyproline during growth, one cannot rule out the possibility that renal factors may play a part in the phenomena described, since it is known that growth hormone (20, 21) and thyroid hormone (20, 22) may influence renal function. Against this possibility, however, is the well documented evidence that renal clearance and glomerular filtration rate expressed per unit surface area, in contrast to hydroxyproline excretion, are low in the first year of life and shortly thereafter attain adult levels that remain constant from then on (20, 23) .
Also, it may be pointed out, total amino acid excretion, mainly in the form of peptides (24) , rose much less than hydroxyproline excretion when measured in one of the pituitary dwarfs. Finally, the increased excretion noted in osteolathyrism is evidence against a renal factor, since hormonal influences capable of affecting renal function were presumably not involved in the lathyritic process.
SUM MARY
Total hydroxyproline excretion has been determined in normal and hospitalized adults and chil-_ dren, in children with dwarfism, and in patients with acromegaly.
Total excretion was significantly greater in children in the 10-to 14-year group than in adults. When calculated per unit body surface area, it was greater in all childhood age groups. Peak levels of excretion per square meter coincided with periods of active growth.
Children with dwarfism showed decreased excretion of hydroxyproline. Administration of growth hormone to two children with pituitary dwarfism and of thyroid hormone to three children with cretinism resulted in a prompt rise in excretion, which attained levels characteristic of rapidly growing children. After cessation of growth hormone administration, excretion fell to pretreatment levels.
One patient with active acromegaly excreted markedly increased amounts of hydroxyproline. After irradiation therapy, these fell toward normal. Five patients with clinically inactive acromegaly showed levels elevated in one case and otherwise in the upper range of normal.
We conclude that there is a close relationship between rate of growth and urinary hydroxyproline excretion, and suggest that the increased excretion is a result of the presence during growth of an increased amount of metabolically active, soluble collagen in the tissues, which is available for breakdown. The results indicate that measurement of urinary hydroxyproline may provide a useful index of growth activity.
